Imagine a World Series hero returning to the team that made him a champion, but this time, he’s battling back from injury and signing a deal that’s a fraction of his previous salary. That’s the story of Jordan Montgomery, who has agreed to a one-year, $1.25 million contract to rejoin the Texas Rangers, according to ESPN. But here’s where it gets intriguing: this isn’t just a feel-good reunion—it’s a calculated move by both player and team, as Montgomery continues his recovery from a second elbow reconstruction surgery.
Let’s rewind for a moment. Montgomery was a key piece of the Rangers’ 2023 World Series triumph, arriving via a trade-deadline deal with the St. Louis Cardinals. He went 4-2 with a stellar 2.79 ERA in 11 regular-season games and played a pivotal role in the AL Championship Series, clinching Game 7. Yet, after becoming a free agent, he signed a massive $25 million deal with the Arizona Diamondbacks—the very team the Rangers defeated in the World Series. And this is the part most people miss: that contract drew harsh criticism from Diamondbacks owner Ken Kendrick, who publicly lamented the decision.
Montgomery’s time in Arizona was rocky. He posted an 8-7 record with a 6.23 ERA in 2024, sidelined for nearly a month with a knee injury and eventually moved to the bullpen. After exercising a $22.5 million option for 2025, he underwent surgery in March, was traded to the Milwaukee Brewers in July, and became a free agent again. Now, he’s back with the Rangers on a deal that pales in comparison to his previous earnings—but could this be a redemption story in the making?
At 33, Montgomery brings experience from eight big league seasons with the New York Yankees, Cardinals, Rangers, and Diamondbacks, boasting a 46-41 record and a 4.03 ERA in 166 games. His journey is a testament to resilience, but it also raises questions: Can he return to his championship-caliber form? And is this a smart gamble for the Rangers?
Here’s the controversial angle: While some see this as a low-risk, high-reward move, others argue it’s a desperate play for a team needing pitching depth. Montgomery’s health remains a question mark, and his recent performance doesn’t inspire confidence. But if he regains even a fraction of his 2023 magic, this could be a steal.
What do you think? Is Montgomery’s return a smart move for the Rangers, or are they setting themselves up for disappointment? Let us know in the comments—this is one reunion that’s sure to spark debate.
